Zai Lab and Amgen Collaborate on Lung Cancer Therapy Trial
Zai Lab Limited has announced a partnership with Amgen to conduct a global clinical trial aimed at evaluating a combination therapy for extensive-stage small cell lung cancer (ES-SCLC). This collaboration is part of Zai Lab's ongoing efforts to develop innovative treatments for cancer patients.
The trial will explore the efficacy of the combined therapies in treating this aggressive form of lung cancer, which is known for its poor prognosis. The collaboration highlights the commitment of both companies to advance cancer treatment options and improve patient outcomes.
© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Source: KLEA News